Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial.

Anan ManomaipiboonKittisak PholtawornkulchaiSujaree PoopipatpabSwangjit SuraamornkulJakravoot ManeeritWiroj RuksakulUraporn PhumisantiphongThananda Trakarnvanich

Published in: Trials (2022)

ClinicalTrials.gov NCT05076253. Registered on 8 October 2021, prospectively.

Keyphrases

double blind
clinical trial
placebo controlled
study protocol
randomized controlled trial
open label